TOSI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 30.807
EU - Europa 16.503
AS - Asia 14.438
SA - Sud America 1.949
AF - Africa 346
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 19
Totale 64.118
Nazione #
US - Stati Uniti d'America 30.352
GB - Regno Unito 4.580
IT - Italia 4.346
SG - Singapore 3.976
CN - Cina 3.912
SE - Svezia 3.077
HK - Hong Kong 1.877
BR - Brasile 1.466
VN - Vietnam 1.456
DE - Germania 915
BD - Bangladesh 673
RU - Federazione Russa 635
FI - Finlandia 614
TR - Turchia 603
UA - Ucraina 591
FR - Francia 535
KR - Corea 476
IN - India 374
BG - Bulgaria 227
CA - Canada 215
NL - Olanda 178
ID - Indonesia 164
AR - Argentina 153
IQ - Iraq 140
JP - Giappone 129
MX - Messico 120
ES - Italia 112
IE - Irlanda 109
ZA - Sudafrica 103
PL - Polonia 84
BE - Belgio 82
PK - Pakistan 82
RO - Romania 78
CO - Colombia 77
EC - Ecuador 73
AE - Emirati Arabi Uniti 69
LT - Lituania 65
MY - Malesia 60
VE - Venezuela 55
CH - Svizzera 53
EG - Egitto 47
IR - Iran 46
IL - Israele 45
AU - Australia 44
UZ - Uzbekistan 40
CL - Cile 39
MA - Marocco 39
PH - Filippine 36
PY - Paraguay 33
DZ - Algeria 31
TN - Tunisia 31
JO - Giordania 29
AT - Austria 28
SA - Arabia Saudita 28
CZ - Repubblica Ceca 27
GR - Grecia 26
KE - Kenya 24
TW - Taiwan 24
NP - Nepal 23
CR - Costa Rica 22
PT - Portogallo 22
TH - Thailandia 22
AZ - Azerbaigian 21
JM - Giamaica 21
KZ - Kazakistan 20
EE - Estonia 19
UY - Uruguay 18
ET - Etiopia 17
PE - Perù 17
BO - Bolivia 16
SN - Senegal 15
DK - Danimarca 14
EU - Europa 14
BY - Bielorussia 12
AL - Albania 11
DO - Repubblica Dominicana 11
LB - Libano 11
NZ - Nuova Zelanda 11
OM - Oman 11
TT - Trinidad e Tobago 11
HU - Ungheria 10
KG - Kirghizistan 10
PA - Panama 10
RS - Serbia 10
NO - Norvegia 9
HN - Honduras 8
KH - Cambogia 8
LY - Libia 8
PS - Palestinian Territory 8
HR - Croazia 7
LK - Sri Lanka 7
NI - Nicaragua 7
PR - Porto Rico 7
AM - Armenia 6
CY - Cipro 6
GE - Georgia 6
KW - Kuwait 6
LA - Repubblica Popolare Democratica del Laos 6
BZ - Belize 5
GT - Guatemala 5
Totale 64.011
Città #
Southend 3.452
Ashburn 2.763
Santa Clara 2.724
Singapore 2.434
Fairfield 2.223
Hong Kong 1.833
Stockholm 1.816
Chandler 1.671
Woodbridge 1.618
Chicago 1.280
Hefei 1.275
Jacksonville 1.140
San Jose 1.020
Houston 1.018
Seattle 965
Wilmington 938
Dearborn 876
Los Angeles 799
Beijing 788
Ann Arbor 776
Nyköping 761
Cambridge 751
London 609
Modena 546
Council Bluffs 513
Ho Chi Minh City 500
Seoul 405
Salt Lake City 401
Helsinki 380
The Dalles 376
New York 368
Izmir 330
Hanoi 324
Milan 302
Dallas 265
Princeton 235
Sofia 216
San Diego 203
Eugene 201
Lauterbourg 197
Rome 184
Bologna 182
Tampa 173
Buffalo 169
Moscow 169
Elk Grove Village 168
São Paulo 143
Shanghai 134
Munich 124
Redwood City 121
Orem 116
Jakarta 114
Frankfurt am Main 107
Tokyo 103
Bremen 94
Falls Church 93
Lancaster 92
Des Moines 85
Dublin 85
Fremont 84
Phoenix 84
Reggio Emilia 80
Sterling 79
Miami 73
Columbus 71
Chennai 69
Naples 69
Brussels 68
Boardman 65
Florence 64
Parma 63
Da Nang 57
Guangzhou 56
Warsaw 55
Haiphong 54
Dulles 53
Johannesburg 51
Brooklyn 50
Montreal 49
Toronto 49
Atlanta 48
Baghdad 48
Denver 46
Detroit 46
Nanjing 46
Amsterdam 43
Turin 43
Catania 41
Como 41
Rio de Janeiro 40
Washington 40
Bari 39
Tulare 39
Norwalk 38
Napoli 37
Manchester 36
Mexico City 36
Palermo 36
Miano 34
Mumbai 34
Totale 43.902
Nome #
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.032
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 593
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 506
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 493
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 476
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 466
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 460
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 456
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 444
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 436
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 435
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 431
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 421
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 420
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 420
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 418
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 415
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 414
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 408
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 406
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 399
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 398
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 397
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 395
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 392
Chemo-enzymatic synthesis of levodropropizine 389
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 387
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 384
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 382
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 379
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 376
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 373
Nanoparticle transport across the blood brain barrier 369
Polymeric nanoparticles for the drug delivery to the central nervous system 369
Vegetable cells in Papanicolaou-stained cervical smears 368
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 368
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 367
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 365
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 362
Brain targeting with polymeric nanoparticles: which administration route should we take? 361
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 360
Nanomedicine: the future for advancing medicine and neuroscience 359
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 359
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 358
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 355
Protein corona and nanoparticles: How can we investigate on? 352
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 348
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 348
Advances and perspectives for Central Nervous System drug delivery: the interface between nanotechnology and neuroscience 347
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 346
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 345
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 343
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 341
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 334
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 333
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 331
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 331
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 331
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 330
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 329
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 329
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 329
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 327
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 326
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 325
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 325
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 323
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 322
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 320
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 318
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 314
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 314
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 314
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 313
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 313
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 312
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 310
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 309
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 307
Functionalization of liposomes: microscopical methods for preformulative screening 306
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 306
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 306
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 305
Colloidal systems for CNS drug delivery 300
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 298
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 297
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 296
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 295
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 295
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 284
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines 282
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 277
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 275
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 274
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 272
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 271
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 271
Brain targeting by engineered nanoparticles 271
Ketorolac tromethamine liposomes: Encapsulation and release studies 270
Totale 37.151
Categoria #
all - tutte 237.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 237.671


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021229 0 0 0 0 0 0 0 0 0 0 0 229
2021/20224.031 178 482 379 242 154 210 213 222 483 320 642 506
2022/20234.655 577 548 362 472 544 622 125 411 528 74 190 202
2023/20243.511 165 197 221 285 793 356 401 418 109 107 169 290
2024/202510.855 500 175 228 827 2.043 1.474 851 771 1.053 466 1.099 1.368
2025/202623.250 1.308 808 1.504 2.778 4.373 1.321 2.161 1.026 3.784 1.901 1.235 1.051
Totale 64.518